David Shaw’s AEON Biopharma Inc AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-154,432
| Closed | -$224K | – | 4959 |
|
|
2024
Q1 | $224K | Hold |
154,432
| – | – | ﹤0.01% | 3880 |
|
|
2023
Q4 | $15.4K | Hold |
154,432
| – | – | ﹤0.01% | 4082 |
|
|
2023
Q3 | $23.2K | Buy |
154,432
+121,099
| +363% | +$17.2K | ﹤0.01% | 3976 |
|
|
2023
Q2 | $3K | Hold |
33,333
| – | – | ﹤0.01% | 4145 |
|
|
2023
Q1 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 4360 |
|
|
2022
Q4 | $1.52K | Hold |
33,333
| – | – | ﹤0.01% | 4779 |
|
|
2022
Q3 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 5095 |
|
|
2022
Q2 | $5K | Hold |
33,333
| – | – | ﹤0.01% | 5234 |
|
|
2022
Q1 | $10K | Hold |
33,333
| – | – | ﹤0.01% | 5413 |
|
|
2021
Q4 | $17K | Hold |
33,333
| – | – | ﹤0.01% | 5303 |
|
|
2021
Q3 | $18K | Hold |
33,333
| – | – | ﹤0.01% | 4900 |
|
|
2021
Q2 | $34K | Buy |
+33,333
| New | +$25.3K | ﹤0.01% | 4656 |
|
David Shaw's AEON.WS Position: Q2 2024 in Review
David Shaw sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 154,432 shares — an estimated $224K sold.
David Shaw first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $224K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.
- David Shaw reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
- David Shaw sold 154,432 AEON Biopharma Inc shares in Q2 2024, an estimated $224K.
- David Shaw first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
- David Shaw's AEON Biopharma Inc position peaked at $224K in Q1 2024.
- 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.